scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2015.03.040 |
P698 | PubMed publication ID | 25820061 |
P2093 | author name string | N Rose | |
M Andraud | |||
O Bourry | |||
P Renson | |||
F Paboeuf | |||
M F Le Potier | |||
P2860 | cites work | Infectiousness of pigs infected by the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) is time-dependent | Q36397345 |
Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States | Q40394450 | ||
Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model | Q41640514 | ||
Results of a control programme for the porcine reproductive and respiratory syndrome in the French 'Pays de la Loire' region | Q43331767 | ||
Infectious agents associated with respiratory diseases in 125 farrow-to-finish pig herds: a cross-sectional study | Q44691563 | ||
Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity. | Q45384517 | ||
Introduction, persistence and fade-out of porcine reproductive and respiratory syndrome virus in a Dutch breeding herd: a mathematical analysis | Q45743752 | ||
Experimental quantification of vaccine-induced reduction in virus transmission | Q45780125 | ||
Design and analysis of small-scale transmission experiments with animals | Q47581066 | ||
Risk factors for porcine post-weaning multisystemic wasting syndrome (PMWS) in 149 French farrow-to-finish herds | Q51649252 | ||
Quantification of transmission in one-to-one experiments. | Q51717662 | ||
Design and analysis of an Actinobacillus pleuropneumoniae transmission experiment | Q73755756 | ||
A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions | Q73980707 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | porcine reproductive and respiratory syndrome virus | Q1760147 |
porcine reproductive and respiratory syndrome | Q2275037 | ||
viral transmission | Q123924092 | ||
P304 | page(s) | 2493-2499 | |
P577 | publication date | 2015-03-26 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Porcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions | |
P478 | volume | 33 |
Q93048878 | A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection |
Q64059321 | A Field Recombinant Strain Derived from Two Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV-1) Modified Live Vaccines Shows Increased Viremia and Transmission in SPF Pigs |
Q40099817 | A Multiplex RT-PCR Assay to Detect and Discriminate Porcine Reproductive and Respiratory Syndrome Viruses in Clinical Specimens |
Q39673041 | A commercial PCV2a-based vaccine significantly reduces PCV2b transmission in experimental conditions. |
Q92081675 | Assessment of pulmonary tissue responses in pigs challenged with PRRSV Lena strain shows better protection after immunization with field than vaccine strains |
Q57092513 | Better horizontal transmission of a US non-InDel strain compared with a French InDel strain of porcine epidemic diarrhoea virus |
Q57811799 | Bottlenecks in the transmission of porcine reproductive and respiratory syndrome virus (PRRSV1) to naïve pigs and the quasi-species variation of the virus during infection in vaccinated pigs |
Q37668276 | Dynamic changes in bronchoalveolar macrophages and cytokines during infection of pigs with a highly or low pathogenic genotype 1 PRRSV strain |
Q45323989 | Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs |
Q50045685 | Estimating Parameters Related to the Lifespan of Passively Transferred and Vaccine-Induced Porcine Reproductive and Respiratory Syndrome Virus Type I Antibodies by Modeling Field Data |
Q36201071 | Evaluation of Control Strategies for Porcine Reproductive and Respiratory Syndrome (PRRS) in Swine Breeding Herds Using a Discrete Event Agent-Based Model |
Q91776607 | Improving the management procedures in farms infected with the Porcine Reproductive and Respiratory Syndrome virus using PDP models |
Q40085086 | In vitro and in vivo studies of deglycosylated chimeric porcine reproductive and respiratory syndrome virus as a vaccine candidate and its realistic revenue impact at commercial pig production level |
Q34483700 | Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction |
Q40621020 | Maternally-derived antibodies (MDAs) impair piglets' humoral and cellular immune responses to vaccination against porcine reproductive and respiratory syndrome (PRRS). |
Q93085100 | Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection |
Q98726777 | Modelling infectious viral diseases in swine populations: a state of the art |
Q54406243 | Modified-live PRRSV subtype 1 vaccine UNISTRAIN® PRRS provides a partial clinical and virological protection upon challenge with East European subtype 3 PRRSV strain Lena. |
Q89981737 | New insights about vaccine effectiveness: Impact of attenuated PRRS-strain vaccination on heterologous strain transmission |
Q40190399 | Oral fluid versus blood sampling in group-housed sows and finishing pigs: Feasibility and performance of antibody detection for porcine reproductive and respiratory syndrome virus (PRRSV). |
Q94660740 | PCV2 co-infection does not impact PRRSV MLV1 safety but enhances virulence of a PRRSV MLV1-like strain in infected SPF pigs |
Q90064898 | Pathogen transmission from vaccinated hosts can cause dose-dependent reduction in virulence |
Q93011930 | Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs |
Q40190413 | Preparation for emergence of an Eastern European porcine reproductive and respiratory syndrome virus (PRRSV) strain in Western Europe: Immunization with modified live virus vaccines or a field strain confers partial protection |
Q28071014 | Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination |
Q40520410 | Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus. |
Q53505792 | The use of vaccines to control pathogen spread in pig populations. |
Q40296647 | Transmission of Porcine reproductive and respiratory syndrome virus 1 to and from vaccinated pigs in a one-to-one model. |
Search more.